scispace - formally typeset
S

Stan Z. Gertler

Researcher at University of Ottawa

Publications -  21
Citations -  591

Stan Z. Gertler is an academic researcher from University of Ottawa. The author has contributed to research in topics: Chemotherapy & Breast cancer. The author has an hindex of 11, co-authored 21 publications receiving 553 citations. Previous affiliations of Stan Z. Gertler include Ottawa Hospital.

Papers
More filters
Journal ArticleDOI

A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia

TL;DR: Ca2+ fluxes through ω-conopeptide-sensitive N-type Ca2+ channels are critically involved in the pathogenesis of selective neuronal death up to 24 h after ischemia in the hippocampus and that this conopeptid protection extends, even when given late, to neocortical infarct reduction.
Journal ArticleDOI

Use of Conjoint Analysis to Assess Breast Cancer Patient Preferences for Chemotherapy Side Effects

TL;DR: In this paper, the authors evaluated preferences associated with grade I/II and grade III/IV chemotherapy side effects among breast cancer patients receiving chemotherapy and assessed trade-offs that patients are willing to make between treatment side effects and the route and schedule of treatment administration.
Journal ArticleDOI

Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase

TL;DR: High dose nitro-arginine caused an increase in hypertension in the spontaneously hypertensive rats and increased the severity of focal ischemia as measured by intra-ischemic regional cerebral blood flows.
Journal ArticleDOI

The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.

TL;DR: The observation that SF remained stable across time is encouraging news, however, longer follow-up and the inclusion of women who were premenopausal at diagnosis are needed to determine the potential influence of extended duration of ET on SD.